Advanced Techniques in Biology & Medicine
Open Access
ISSN: 2379-1764
ISSN: 2379-1764
Department of Immunology, Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Hebei Medical University, Shijiazhuang, China
Cuiqing Ma is from Department of Immunology, Hebei Medical University, Shijiazhuang, China. The main area of Cuiqing Ma research is Tumor Immunology, Transplantation Immunology, Immunology of Infectious, Diseases, Autoimmunity, Immunology of Barrier Surfaces, Basic Immunologic Mechanisms, Center for Systems Immunology. Cuiqing Ma studies have been published in some of main worldwide journals.
Research Article
Adjuvant Option for Effective SARS-CoV-2 Vaccine
Author(s): Ling Xue, Jiao Li, Lin Wei, Cuiqing Ma* and Suiyi Tan
Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2 infection, has spread all over the world as an emerging infectious disease, causing a very serious impact on the global economy and public health. To date, there is no specific treatment or vaccines against coronaviruses. To prevent the infection and stop the pandemic, the research and development of effective SARS-CoV-2 vaccines has become an urgent matter. It is worth mentioning that appropriate adjuvants could enhance the strength and speed of the immune responses to vaccination. However, it takes time to customize different adjuvants with distinct targets (cellular or humoral immunity) and action intensity according to different antigens. In this review, we summarize the mechanism, advantages and disadvantages of adjuvants commonly used in licensed vaccines, as well as some novel adjuvants under development, hoping to provi.. View More»
DOI:
10.35248/2379-1764.20.8.274